RevOpsis Therapeutics
Funding Round: Seed
Amount: $16.5M
Investors:
a leading contract development and manufacturing organization (CDMO) with global commercial drug supply capabilities, an ophthalmic drug and device development firm, and various private and angel investors...
Markets:
Biotechnology, Pharmaceuticals, Ophthalmology
HQ: Springfield, Illinois, United States
Date: 25-Apr-2024